CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
Theta TMS +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03828734
NCT03828734N/ACompleted
CompareCT.gov

Modulation of Alpha and Theta Oscillations in a Cognitive Control Retrospective Cue Task With Frequency Specific Rhythmic Transcranial Magnetic Stimulation

University of North Carolina, Chapel Hill·interventional·Posted Feb 4, 2019·Updated Nov 19, 2020

In Brief

A clinical study evaluating Theta TMS, Alpha TMS, and 1 other intervention for Executive Function. Completed, enrolled 58 participants across 1 site.

Detailed Summary

Purpose: In this study, the investigators will provide causal evidence for the role of alpha and theta oscillations in cognitive control. Participants: Participants must be healthy, between the ages of 18 and 35, right handed, able to provide informed consent, willing to comply with all study procedures, and be available for the duration of the study, speak and understand English. Procedures: Alpha and theta brain oscillations will be measured and then entrained using frequency specific rhythmic TMS during a retrospective cued cognitive control task.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsExecutive Function
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 4, 2019
Enrollment StartFeb 13, 2019
Primary CompletionNov 22, 2019
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.4 years ago

Interventions

Theta TMSdevice

TMS will be administered at the frequency of each subject's endogenous theta oscillation (4-7Hz)

Alpha TMSdevice

TMS will be administered at the frequency of each subject's endogenous alpha oscillation (8-12 Hz)

Arrhythmic TMSdevice

TMS will be administered arrhythmically; i.e. a sequence of pulses with randomized timing